FDA Clearance Archives - Cardio Flow, Inc.

Cardio Flow Announces Completion of First Commercial Cases of Innovative FreedomFlow Orbital Atherectomy Platform—and Appointment of Chief Operating Officer

Cardio Flow Announces Completion of First Commercial Cases—and Appointment of Chief Operating Officer

October 30, 2023
FDA Clearance, FreedomFlow Orbital Atherectomy Platform

PRESS RELEASE | FOR IMMEDIATE RELEASE | Download press release St. Paul, MN – October 30, 2023. Cardio Flow, Inc., a privately held commercial-stage medical device company and developer of minimally invasive devices to treat…

FreedomFlow Orbital Atherectomy Platform Receives FDA 510(k) Clearance to Treat Peripheral Artery Disease

October 17, 2023
FDA Clearance, FreedomFlow Peripheral Guidewire

PRESS RELEASE | FOR IMMEDIATE RELEASE | Download press release St. Paul, MN – October 18, 2023. Cardio Flow, Inc., a privately held medical device company and developer of minimally invasive devices to treat peripheral…

Cardio Flow, Inc., Announces FDA Clearance for FreedomFlow Peripheral Guidewire, plus First Commercial Case Completed in U.S.

June 2, 2022
FDA Clearance, FreedomFlow Peripheral Guidewire

PRESS RELEASE | FOR IMMEDIATE RELEASE | Download press release St. Paul, MN – June 2, 2022 – Cardio Flow, Inc., a medical device company and developer of minimally invasive peripheral vascular devices to treat…